TOBRADEX

3MG/ML+1MG/ML OPH GTT SUS 1X5ML

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 20.12.2021
Interruption of marketing 09.12.2021 0180988, 0223560
Léky s jinou kombinací antibiotika a kortikoidu - dle uvážení lékaře
Manufacturing reasons 07.01.2022
Placing on the market 10.10.2017

All reports are available in the Overview.

Back to list